Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LAPATINIB DITOSYLATE Cause Death? 665 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 665 reports of Death have been filed in association with LAPATINIB DITOSYLATE (Lapatinib). This represents 16.8% of all adverse event reports for LAPATINIB DITOSYLATE.

665
Reports of Death with LAPATINIB DITOSYLATE
16.8%
of all LAPATINIB DITOSYLATE reports
664
Deaths
22
Hospitalizations

How Dangerous Is Death From LAPATINIB DITOSYLATE?

Of the 665 reports, 664 (99.8%) resulted in death, 22 (3.3%) required hospitalization, and 2 (0.3%) were considered life-threatening.

Is Death Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LAPATINIB DITOSYLATE. However, 665 reports have been filed with the FAERS database.

What Other Side Effects Does LAPATINIB DITOSYLATE Cause?

Diarrhoea (893) Nausea (317) Fatigue (301) Vomiting (259) Rash (249) Drug ineffective (183) Malignant neoplasm progression (183) Off label use (141) Disease progression (137) Palmar-plantar erythrodysaesthesia syndrome (135)

What Other Drugs Cause Death?

OXYCODONE (23,259) LENALIDOMIDE (19,213) APIXABAN (18,501) MORPHINE (17,960) ACETAMINOPHEN\OXYCODONE (17,849) FENTANYL (16,577) DENOSUMAB (16,545) ACETAMINOPHEN\HYDROCODONE (16,341) HYDROMORPHONE (15,276) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (13,789)

Which LAPATINIB DITOSYLATE Alternatives Have Lower Death Risk?

LAPATINIB DITOSYLATE vs LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN LAPATINIB DITOSYLATE vs LARONIDASE LAPATINIB DITOSYLATE vs LAROTRECTINIB LAPATINIB DITOSYLATE vs LASILIX LAPATINIB DITOSYLATE vs LASIX

Related Pages

LAPATINIB DITOSYLATE Full Profile All Death Reports All Drugs Causing Death LAPATINIB DITOSYLATE Demographics